Press Releases

Featured Press Releases

BIO Applauds Introduction of Bipartisan…

BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…

Learn more

BIO International Convention Celebrates Another…

Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…

Learn more

BIO Recognizes Industry Leaders for…

WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…

Learn more

BIO Elects Paul Hastings as New Board Chair

June 11, 2021

New Officers Join BIO’s Governing Boards

BIO Takes on Health Equity in Clinical Trials

June 10, 2021

First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem

BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations

May 18, 2021

"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…

BIO Extends Agreement with Avantor

May 10, 2021

Today, the Biotechnology Innovation Organization (BIO) announced an extension through June 2029 to its established agreement with Avantor. Through this agreement, members across North America have access to a broad…

Support of "TRIPS" Waiver Sets Dangerous Precedent

May 5, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…

Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs

May 4, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…

BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH

May 3, 2021

Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders

BIO's Dr. Michelle McMurry-Heath Comments on Passage of Washington State's Clean Fuel Standard

April 26, 2021

BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement following the passage of a clean fuel standard bill (HB 1091) in Washington state. "With the passage of HB 1091, Washington state is showing once again that climate…

H.R. 3 To Handicap Future Medical Innovation, Destroy Hope for Vulnerable Patients

April 22, 2021

Following the re-introduction of the H.R. 3 drug pricing legislation, Rich Masters -- Chief Public Affairs and Advocacy Officer of the Biotechnology Innovation Organization (BIO) -- made the following remarks: "On behalf of BIO’s…

Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries

April 20, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.